{"database": "lobbying", "table": "lobbying_activities", "rows": [[2510175, "9ca052c5-d56d-4048-9732-79fd043ac0ec", "Q3", "MICHAEL N. MCCARTY LAW OFFICE PLLC", 401104300, "AMERICAN MEDICAL TECHNOLOGISTS", 2020, "third_quarter", "MED", "Appropriations for CDC initiative to establish pediatric reference intervals for clinical diagnostic testing; prospective legislation to regulate in vitro clinical diagnostic tests, including the Verifying Accurate, Leading-edge IVCT Development (VALID) Act (H.R.6102; S.3404); and the Verified Innovative Testing in American Laboratories (VITAL) Act (S.3512); Coronavirus relief and stimulus legislation as it relates to clinical laboratories and medical practices; coronavirus testing supply chain issues.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 10000, null, 0, 0, "2020-10-15T19:31:59.310000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2510175"], "units": {}, "query_ms": 0.3405129536986351, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}